Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for PROCEPT BioRobotics Corporation (PRCT : NSDQ)
 
 • Company Description   
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics Corporation is based in REDWOOD CITY, Calif.

Number of Employees: 756

 
 • Price / Volume Information   
Yesterday's Closing Price: $31.46 Daily Weekly Monthly
20 Day Moving Average: 1,163,826 shares
Shares Outstanding: 55.88 (millions)
Market Capitalization: $1,757.94 (millions)
Beta: 0.99
52 Week High: $89.49
52 Week Low: $27.80
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -11.20% -11.05%
12 Week -9.68% -11.13%
Year To Date 0.00% 0.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
150 Baytech Drive
-
San Jose,CA 95134
USA
ph: 650-232-7200
fax: -
ir@procept-biorobotics.com http://www.procept-biorobotics.com
 
 • General Corporate Information   
Officers
Reza Zadno - President; Chief Executive Officer and Director
Thomas M. Prescott - Director and Chairman of the Board
Antal Desai - Director
Amy Dodrill - Director
Mary Garrett - Director

Peer Information
PROCEPT BioRobotics Corporation (ABMD)
PROCEPT BioRobotics Corporation (DMDS)
PROCEPT BioRobotics Corporation (CPWY.)
PROCEPT BioRobotics Corporation (EQUR)
PROCEPT BioRobotics Corporation (ECIA)
PROCEPT BioRobotics Corporation (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 74276L105
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/24/26
Share - Related Items
Shares Outstanding: 55.88
Most Recent Split Date: (:1)
Beta: 0.99
Market Capitalization: $1,757.94 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.32 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.06 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 21.70% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/24/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 4.62
Price/Cash Flow: -
Price / Sales: 5.86
EPS Growth
vs. Year Ago Period: 5.00%
vs. Previous Quarter: -8.57%
Sales Growth
vs. Year Ago Period: 42.76%
vs. Previous Quarter: 5.23%
ROE
12/31/25 - -
09/30/25 - -21.72
06/30/25 - -23.73
ROA
12/31/25 - -
09/30/25 - -16.28
06/30/25 - -17.34
Current Ratio
12/31/25 - -
09/30/25 - 8.44
06/30/25 - 9.21
Quick Ratio
12/31/25 - -
09/30/25 - 7.20
06/30/25 - 7.86
Operating Margin
12/31/25 - -
09/30/25 - -28.20
06/30/25 - -30.60
Net Margin
12/31/25 - -
09/30/25 - -28.20
06/30/25 - -30.60
Pre-Tax Margin
12/31/25 - -
09/30/25 - -28.20
06/30/25 - -30.60
Book Value
12/31/25 - -
09/30/25 - 6.81
06/30/25 - 6.97
Inventory Turnover
12/31/25 - -
09/30/25 - 1.69
06/30/25 - 1.67
Debt-to-Equity
12/31/25 - -
09/30/25 - 0.14
06/30/25 - 0.13
Debt-to-Capital
12/31/25 - -
09/30/25 - 11.94
06/30/25 - 11.78
 

Powered by Zacks Investment Research ©